Austin, TX 12/4/2007 11:42:27 PM
Speak with other shareholders about: (OTCBB: MGEN), (NYSE: VMW), (OTCBB: CLBE), (NASDAQ: ORCL), (OTCBB: UDTT).
Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in the top 5,000 websites in the United States by Alexa.com/Amazon.com, has created one of the finest chat programs available for investors. Now you can chat real-time with like-minded individuals about your favorite stock. Visit Stockwire.com and click the Chat Live button at the top.
----------------------------------------------------------
Chat real-time with other investors about this MGEN news release,
by clicking this link: http://www.stockwire.com/MGEN
To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=MGEN
Med Gen Inc (OTCBB: MGEN), up 1% on 32 million shares, a manufacturer of nationally branded OTC healthier life products and speciality financial services, declared on 3 December that its unaudited revenue as of 30 November 2007 was USD360,000, 191% more than the comparable period in 2006. The company reported that liquidity in the form of cash on hand or cash equivalents exceeds USD 725,000.
----------------------------------------------------------
Chat real-time with other investors about this VMW news release,
by clicking this link: http://www.stockwire.com/VMW
To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=VMW
VMware, Inc. (NYSE: VMW), down 1% on 36 million shares, the virtualization software leader, yesterday announced Diane Greene, president and chief executive officer of VMware, is scheduled to present at the Lehman Brothers Annual Technology Conference in San Francisco on Wednesday, December 5 at 7:30 a.m. PT / 10:30 a.m. ET. Greene's presentation will be webcast live at http://ir.vmware.com. A replay will be available for approximately twelve months at the same location.
----------------------------------------------------------
Chat real-time with other investors about this CLBE news release,
by clicking this link: http://www.stockwire.com/CLBE
To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=CLBE
CalbaTech, Inc. (OTCBB: CLBE), down 21% on 18 million shares, an emerging life sciences company (http://www.CalbaTech.com) concentrating on the collection and banking of adult stem cells for possible future therapeutic uses and providing products and platforms to the biotech and pharmaceutical research markets and to academic institutions, announced Friday that the California Department of Public Health has renewed LifeStem's biologics license.
----------------------------------------------------------
Chat real-time with other investors about this ORCL news release,
by clicking this link: http://www.stockwire.com/ORCL
To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=ORCL
Oracle Corporation (NASDAQ: ORCL), up .3% on 36 million shares, said yesterday "Oracle Content Management offers unparalleled functionality and ease-of-use for customers seeking to gain control, manage access and help ensure compliance across myriad forms of enterprise content.
----------------------------------------------------------
Chat real-time with other investors about this UDTT news release,
by clicking this link: http://www.stockwire.com/UDTT
To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=UDTT
Universal Detection Technology (OTCBB: UDTT), down 1% on 18 million shares, a developer of early-warning monitoring technologies to protect people from bioterrorism and a provider of counter-terrorism training and solutions, announced today that it has received a purchase order for five-agent bioterrorism detection kits from Gulf Security Solutions in Dubai.
--------------------------------------------------
About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission (SEC) at www.sec.gov and/or the National Association of Securities Dealers (NASDAQ) at www.NASDAQ.com. The NASDAQ has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.
We often receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. On occasion, we also accept free-trading shares in a company that we cover. We intend to sell these shares into the open market.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .
The Stockwire Group .
512.358.8440 .
info@stockwire.com .
